KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Asml Holding (ASML) Asset Writedowns and Impairment (2016 - 2021)

Historic Asset Writedowns and Impairment for Asml Holding (ASML) over the last 17 years, with Q1 2025 value amounting to $62.7 million.

  • Asml Holding's Asset Writedowns and Impairment fell 5253.11% to $62.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was $531.0 million, marking a year-over-year decrease of 662.71%. This contributed to the annual value of $592.7 million for FY2024, which is 1352.02% up from last year.
  • Per Asml Holding's latest filing, its Asset Writedowns and Impairment stood at $62.7 million for Q1 2025, which was down 5253.11% from $179.2 million recorded in Q4 2024.
  • Asml Holding's Asset Writedowns and Impairment's 5-year high stood at $226.7 million during Q4 2023, with a 5-year trough of $41.4 million in Q2 2021.
  • Over the past 5 years, Asml Holding's median Asset Writedowns and Impairment value was $82.4 million (recorded in 2022), while the average stood at $99.5 million.
  • In the last 5 years, Asml Holding's Asset Writedowns and Impairment surged by 21164.31% in 2023 and then tumbled by 5253.11% in 2025.
  • Asml Holding's Asset Writedowns and Impairment (Quarter) stood at $56.5 million in 2021, then increased by 28.72% to $72.7 million in 2022, then surged by 211.64% to $226.7 million in 2023, then decreased by 20.95% to $179.2 million in 2024, then plummeted by 65.04% to $62.7 million in 2025.
  • Its Asset Writedowns and Impairment stands at $62.7 million for Q1 2025, versus $179.2 million for Q4 2024 and $170.0 million for Q3 2024.